Business Earnings Snapshot: Teladoc Health guidance falls short; U.S. revenue down 3%, international up 19%
Business The Trade Desk in charts: Q4 revenue, adjusted EBIDTA seen up double digits; cash reserves decline
Business FS KKR Capital slashes quarterly dividend by 29.7% to $0.45 and supplemental distribution of $0.03 per share
Business RxSight outlines $120M–$135M 2026 revenue guidance while strengthening commercial initiatives
Business Revolution Medicines outlines $1.6B–$1.7B 2026 operating expenses as RAS(ON) inhibitor trials expand
Business The Trade Desk outlines at least $678M Q1 revenue target as AI innovation and CTV momentum continue